These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage. Bosch J P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206 [TBL] [Abstract][Full Text] [Related]
5. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041 [TBL] [Abstract][Full Text] [Related]
13. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis. Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728 [TBL] [Abstract][Full Text] [Related]
14. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Bosch J; Iwakiri Y Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029 [TBL] [Abstract][Full Text] [Related]
15. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding. Garbuzenko DV Curr Med Res Opin; 2016; 32(3):467-75. PubMed ID: 26804426 [TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930 [TBL] [Abstract][Full Text] [Related]
18. Therapies: Drugs, Scopes and Transjugular Intrahepatic Portosystemic Shunt--When and How? Abraldes JG; Tandon P Dig Dis; 2015; 33(4):524-33. PubMed ID: 26159269 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985 [TBL] [Abstract][Full Text] [Related]
20. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy. Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R; Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]